Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1
Abstract Screening of a carefully selected library of 5,195 small molecules identified 34 hit compounds that interact with the regulatory cyclic nucleotide-binding domain (CNB) of the cAMP sensor, EPAC1. Two of these hits (I942 and I178) were selected for their robust and reproducible inhibitory eff...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c91ea91952a24175bdc43cc328f5f816 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c91ea91952a24175bdc43cc328f5f816 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c91ea91952a24175bdc43cc328f5f8162021-12-02T12:32:53ZIdentification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC110.1038/s41598-017-00455-72045-2322https://doaj.org/article/c91ea91952a24175bdc43cc328f5f8162017-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-00455-7https://doaj.org/toc/2045-2322Abstract Screening of a carefully selected library of 5,195 small molecules identified 34 hit compounds that interact with the regulatory cyclic nucleotide-binding domain (CNB) of the cAMP sensor, EPAC1. Two of these hits (I942 and I178) were selected for their robust and reproducible inhibitory effects within the primary screening assay. Follow-up characterisation by ligand observed nuclear magnetic resonance (NMR) revealed direct interaction of I942 and I178 with EPAC1 and EPAC2-CNBs in vitro. Moreover, in vitro guanine nucleotide exchange factor (GEF) assays revealed that I942 and, to a lesser extent, I178 had partial agonist properties towards EPAC1, leading to activation of EPAC1, in the absence of cAMP, and inhibition of GEF activity in the presence of cAMP. In contrast, there was very little agonist action of I942 towards EPAC2 or protein kinase A (PKA). To our knowledge, this is the first observation of non-cyclic-nucleotide small molecules with agonist properties towards EPAC1. Furthermore, the isoform selective agonist nature of these compounds highlights the potential for the development of small molecule tools that selectively up-regulate EPAC1 activity.Euan ParnellStuart P. McElroyJolanta WiejakGemma L. BaillieAlison PorterDavid R. AdamsHolger RehmannBrian O. SmithStephen J. YarwoodNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-12 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Euan Parnell Stuart P. McElroy Jolanta Wiejak Gemma L. Baillie Alison Porter David R. Adams Holger Rehmann Brian O. Smith Stephen J. Yarwood Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1 |
description |
Abstract Screening of a carefully selected library of 5,195 small molecules identified 34 hit compounds that interact with the regulatory cyclic nucleotide-binding domain (CNB) of the cAMP sensor, EPAC1. Two of these hits (I942 and I178) were selected for their robust and reproducible inhibitory effects within the primary screening assay. Follow-up characterisation by ligand observed nuclear magnetic resonance (NMR) revealed direct interaction of I942 and I178 with EPAC1 and EPAC2-CNBs in vitro. Moreover, in vitro guanine nucleotide exchange factor (GEF) assays revealed that I942 and, to a lesser extent, I178 had partial agonist properties towards EPAC1, leading to activation of EPAC1, in the absence of cAMP, and inhibition of GEF activity in the presence of cAMP. In contrast, there was very little agonist action of I942 towards EPAC2 or protein kinase A (PKA). To our knowledge, this is the first observation of non-cyclic-nucleotide small molecules with agonist properties towards EPAC1. Furthermore, the isoform selective agonist nature of these compounds highlights the potential for the development of small molecule tools that selectively up-regulate EPAC1 activity. |
format |
article |
author |
Euan Parnell Stuart P. McElroy Jolanta Wiejak Gemma L. Baillie Alison Porter David R. Adams Holger Rehmann Brian O. Smith Stephen J. Yarwood |
author_facet |
Euan Parnell Stuart P. McElroy Jolanta Wiejak Gemma L. Baillie Alison Porter David R. Adams Holger Rehmann Brian O. Smith Stephen J. Yarwood |
author_sort |
Euan Parnell |
title |
Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1 |
title_short |
Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1 |
title_full |
Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1 |
title_fullStr |
Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1 |
title_full_unstemmed |
Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1 |
title_sort |
identification of a novel, small molecule partial agonist for the cyclic amp sensor, epac1 |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/c91ea91952a24175bdc43cc328f5f816 |
work_keys_str_mv |
AT euanparnell identificationofanovelsmallmoleculepartialagonistforthecyclicampsensorepac1 AT stuartpmcelroy identificationofanovelsmallmoleculepartialagonistforthecyclicampsensorepac1 AT jolantawiejak identificationofanovelsmallmoleculepartialagonistforthecyclicampsensorepac1 AT gemmalbaillie identificationofanovelsmallmoleculepartialagonistforthecyclicampsensorepac1 AT alisonporter identificationofanovelsmallmoleculepartialagonistforthecyclicampsensorepac1 AT davidradams identificationofanovelsmallmoleculepartialagonistforthecyclicampsensorepac1 AT holgerrehmann identificationofanovelsmallmoleculepartialagonistforthecyclicampsensorepac1 AT brianosmith identificationofanovelsmallmoleculepartialagonistforthecyclicampsensorepac1 AT stephenjyarwood identificationofanovelsmallmoleculepartialagonistforthecyclicampsensorepac1 |
_version_ |
1718393946031259648 |